Phase I and phototoxicity studies of pseudourea (NSC-56054).
D000873:Anthracenes / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D009362:Neoplasm Metastasis / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D010787:Photosensitivity Disorders / Q000139:chemically induced; D013890:Thiourea / Q000627:therapeutic use* / Q000031:analogs & derivatives
D000873:Anthracenes; D000970:Antineoplastic Agents; C000132:pseudourea; D013890:Thiourea